1. Home
  2. APYX vs ACET Comparison

APYX vs ACET Comparison

Compare APYX & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APYX
  • ACET
  • Stock Information
  • Founded
  • APYX 1982
  • ACET 1947
  • Country
  • APYX United States
  • ACET United States
  • Employees
  • APYX N/A
  • ACET N/A
  • Industry
  • APYX Medical/Dental Instruments
  • ACET Biotechnology: Pharmaceutical Preparations
  • Sector
  • APYX Health Care
  • ACET Health Care
  • Exchange
  • APYX Nasdaq
  • ACET Nasdaq
  • Market Cap
  • APYX 85.0M
  • ACET 69.9M
  • IPO Year
  • APYX 1987
  • ACET N/A
  • Fundamental
  • Price
  • APYX $2.39
  • ACET $0.83
  • Analyst Decision
  • APYX Hold
  • ACET Buy
  • Analyst Count
  • APYX 1
  • ACET 4
  • Target Price
  • APYX N/A
  • ACET $5.50
  • AVG Volume (30 Days)
  • APYX 67.6K
  • ACET 439.6K
  • Earning Date
  • APYX 11-07-2025
  • ACET 11-05-2025
  • Dividend Yield
  • APYX N/A
  • ACET N/A
  • EPS Growth
  • APYX N/A
  • ACET N/A
  • EPS
  • APYX N/A
  • ACET N/A
  • Revenue
  • APYX $46,512,000.00
  • ACET N/A
  • Revenue This Year
  • APYX $6.03
  • ACET N/A
  • Revenue Next Year
  • APYX $4.96
  • ACET N/A
  • P/E Ratio
  • APYX N/A
  • ACET N/A
  • Revenue Growth
  • APYX N/A
  • ACET N/A
  • 52 Week Low
  • APYX $0.76
  • ACET $0.45
  • 52 Week High
  • APYX $2.73
  • ACET $1.54
  • Technical
  • Relative Strength Index (RSI)
  • APYX 62.75
  • ACET 57.00
  • Support Level
  • APYX $2.06
  • ACET $0.79
  • Resistance Level
  • APYX $2.20
  • ACET $0.87
  • Average True Range (ATR)
  • APYX 0.16
  • ACET 0.04
  • MACD
  • APYX 0.02
  • ACET -0.00
  • Stochastic Oscillator
  • APYX 98.57
  • ACET 67.11

About APYX Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

Share on Social Networks: